By coating biodegradable nanoparticles with macrophage membranes, scientists developed a targeted antifungal delivery platform that increased drug accumulation at infection sites and improved treatment efficacy in preclinical studies. The post Macrophage Membrane-Derived Nanoparticles Shows Potential Against Candida Infections appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
Ag Genomics Begins to Bear Fruit
[Podcast] From Protocol to Patient: Inside Clinical...
KKR-backed Allyntra debuts to serve medtech industry...
IHealthScreen nabs FDA nod for AI-backed dx to spot...
‘How did they get there first?’ Biotechs forced to...
Deals, deals, deals; Biohaven takes on Eli Lilly; and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.